Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Niren Murthy
Georgia Institute of Technology, Department: Chemistry
Should you be removed from our database? Contact us at [email protected]. Read more below.
Microbial Medical
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Microbial Medical is focused on imaging bacterial infections in vivo with maltodextrins. The proposal is focused on developing point of care assays that can detect bacterial MIC’s in blood. It uses the transporter as a way of labeling bacteria in blood which if successful could increase the value of the IP. The experiments in the proposal are related to the claims of the patents that Microbial Medical has licensed.
Rapid antimicrobial susceptibility determination of bacterial pathogens
This proposal develops new technologies to speed antimicrobial sensitivity testing from the current ~42 hours to ~4 hours after positive blood culture using both fluorescent and label-free detection. Actionable treatment information requires both identification and antibiotic sensitivity determinations - the latter being the true bottleneck in treatment that both negatively impacts patient health and increases antibiotic resistance through empiric treatments. New flow cytometric scatter and fluorescence sensing measurements, coupled with adaptive, multidimensional statistical methods developed specifically for this purpose suggest eventual translation to the clinic to positively impact treatment and overall human health.
Filed on May 19, 2017.
Tell us what you know about Niren Murthy's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Niren Murthy”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Niren Murthy | University of California Berkeley | Financial Disclosure | Microbial Medical | |
| Niren Murthy | University of California Berkeley | Financial Disclosure | Microbial Medical | |
| Niren Murthy | University of California Berkeley | Financial Disclosure | GenEdit | |
| Niren Murthy | Emory University | Conflict of Interest | Microbial Medical | Value cannot be readily determined |
| Niren Murthy | University of California Berkeley | Financial Disclosure | Microbial Medical, Inc. | |
| Niren Murthy | University of California Berkeley | Conflict of Interest | Microbial Medical | Value cannot be readily determined |
| Niren Murthy | University of California Berkeley | Conflict of Interest | GenEdit | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.